Association of Selected Medical Conditions With Breast Cancer Risk in Korea
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: To estimate the effect of medical conditions in the population of Korea on breast cancer risk in a case-control study. Methods: The cases were 3242 women with incident, histologically confirmed breast cancer in two major hospitals interviewed between 2001 and 2007. The controls were 1818 women each admitted to either of those two hospitals for a variety of non-neoplastic conditions. Information on each disease was obtained from a standardized questionnaire by trained personnel. Odds ratios (ORs) for each disease were derived from multiple logistic regression adjusted for age, age of menarche, pregnancy, age of first pregnancy, and family history of breast cancer. Results: Among all of the incident breast cancer patients, pre-existing diabetes (OR, 1.33; 95% confidence interval [CI], 0.99 to 1.78), hypertension (OR, 1.46; 95% CI, 1.18 to 1.83), thyroid diseases (OR, 1.26; 95% CI, 1.00 to 1.58), and ovarian diseases (OR, 1.70; 95% CI, 1.23 to 2.35) were associated with an increased risk of breast cancer when other factors were adjusted for. In a stratified analysis by menopausal status, pre-existing hypertension (pre-menopause OR, 0.80; 95% CI, 0.48 to 1.34 vs. post-menopause OR, 1.87; 95% CI, 1.44 to 2.43; p-heterogeneity <0.01) and ovarian disease (pre-menopause OR, 4.20; 95% CI, 1.91 to 9.24 vs. post-menopause OR, 1.39; 95% CI, 1.02 to 1.91; p-heterogeneity 0.01) showed significantly different risks of breast cancer. Conclusions: Our results suggest the possibility that medical conditions such as hypertension affect breast cancer development, and that this can differ by menopausal status. Our study also indicates a possible correlation between ovarian diseases and breast cancer risk.
Abstract
Objectives: To estimate the effect of medical conditions in the population of Korea on breast cancer risk in a case-control study. Methods: The cases were 3242 women with incident, histologically confirmed breast cancer in two major hospitals interviewed between 2001 and 2007. The controls were 1818 women each admitted to either of those two hospitals for a variety of non-neoplastic conditions. Information on each disease was obtained from a standardized questionnaire by trained personnel. Odds ratios (ORs) for each disease were derived from multiple logistic regression adjusted for age, age of menarche, pregnancy, age of first pregnancy, and family history of breast cancer. Results: Among all of the incident breast cancer patients, pre-existing diabetes (OR, 1.33; 95% confidence interval [CI], 0.99 to 1.78), hypertension (OR, 1.46; 95% CI, 1.18 to 1.83), thyroid diseases (OR, 1.26; 95% CI, 1.00 to 1.58), and ovarian diseases (OR, 1.70; 95% CI, 1.23 to 2.35) were associated with an increased risk of breast cancer when other factors were adjusted for. In a stratified analysis by menopausal status, pre-existing hypertension (pre-menopause OR, 0.80; 95% CI, 0.48 to 1.34 vs. post-menopause OR, 1.87; 95% CI, 1.44 to 2.43; p-heterogeneity <0.01) and ovarian disease (pre-menopause OR, 4.20; 95% CI, 1.91 to 9.24 vs. post-menopause OR, 1.39; 95% CI, 1.02 to 1.91; p-heterogeneity 0.01) showed significantly different risks of breast cancer. Conclusions: Our results suggest the possibility that medical conditions such as hypertension affect breast cancer development, and that this can differ by menopausal status. Our study also indicates a possible correlation between ovarian diseases and breast cancer risk.
참고문헌 (40)
- 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2013", Cancer Research and Treatment, 45(1), pp.15~21 (2013), 대한암학회
- Siegel R, "Cancer statistics, 2012", CA Cancer J Clin, 62(1), pp.10~29 (2012)
- Jemal A, "Global cancer statistics", CA Cancer J Clin, 61(2), pp.69~90 (2011)
- Kohler BA, "Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system", J Natl Cancer Inst, 103(9), pp.714~736 (2011)
- Nichols HB, "Declining incidence of contralateral breast cancer in the United States from 1975 to 2006", J Clin Oncol, 29(12), pp.1564~1569 (2011)
- Kelsey JL, "Reproductive factors and breast cancer", Epidemiol Rev, 15(1), pp.36~47 (1993)
- Collaborative Group on Hormonal Factors in Breast Cancer, "Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the dis ease", Lancet, 358(9291), pp.1389~1399 (2001)
- Henderson TO, "Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer", Ann Intern Med, 152(7), pp.444~455 (2010)
- Singletary KW, "Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms", JAMA, 286(17), pp.2143~2151 (2001)
- Reynolds P, "Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study", J Natl Cancer Inst, 96(1), pp.29~37 (2004)
- Bernstein L, "Endogenous hormones and breast cancer risk", Epidemiol Rev, 15(1), pp.48~65 (1993)
- Goldman MB, "Thyroid diseases and breast cancer", Epidemiol Rev, 12, pp.16~28 (1990)
- Weiss HA, "Breast cancer risk in young women and history of selected medical conditions", J Epidemiol, 28(5), pp.816~823 (1999)
- Larsson SC, "Diabetes mellitus and risk of breast cancer: a meta-analysis", J Cancer, 121(4), pp.856~862 (2007)
- Peeters PH, "Hypertension and breast cancer risk in a 19-year follow-up study (the DOM cohort). Diagnostic investigation into mammarian cancer", J Hypertens, 18(3), pp.249~254 (2000)
- Vojtechova P, "The association of atopic diseases with breast, prostate, and colorectal cancers: a meta-analysis", Cancer Causes Control, 20(7), pp.1091~1105 (2009)
- Wiseman H, "Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer", Biochem J, 313(1), pp.17~29 (1996)
- Chung S, "Association between chronological change of reproductive factors and breast cancer risk defined by hormone receptor status: results from the Seoul Breast Cancer Study", Breast Cancer Res Treat, 140(3), pp.557~565 (2013)
- Choi JY, "Association of paternal age at birth and the risk of breast cancer in offspring: a case control study", BMC Cancer, 5, pp.143~ (2005)
- Largent JA, "Hypertension, diuretics and breast cancer risk", J Hum Hypertens, 20(10), pp.727~732 (2006)
- Nordén A, "Letter: Hypertension related to D.N.A. repair synthesis and carcinogen uptake", Lancet, 2(7944), pp.1094~ (1975)
- Hamet P, "Cancer and hypertension: a potential for crosstalk?", J Hypertens, 15(12-2), pp.1573~1577 (1997)
- Kaaks R, "Nutrition, hormones, and breast cancer: is insulin the missing link?", Cancer Causes Control, 7(6), pp.605~625 (1996)
- Soler M, "Hypertension and hormone-related neoplasms in women", Hypertension, 34(2), pp.320~325 (1999)
- Jee SH, "Fasting serum glucose level and cancer risk in Korean men and women", JAMA, 293(2), pp.194~202 (2005)
- Wideroff L, "Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark", J Natl Cancer Inst, 89(18), pp.1360~1365 (1997)
- Cannata D, "Type 2 diabetes and cancer: what is the connection?", Mt Sinai J Med, 77(2), pp.197~213 (2010)
- Van der Burg B, "Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen", J Cell Physiol, 134(1), pp.101~108 (1988)
- Rose DP, "Obesity, adipocytokines, and insulin resistance in breast cancer", Obes Rev, 5(3), pp.153~165 (2004)
- Peyrat JP, "Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer", Eur J Cancer, 29(4), pp.492~497 (1993)
- Oliveras-Ferraros C, "Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: induction of the tumor suppressor miRNA let-7a and suppression of the TGFβ-induced oncomiR miRNA-181a", Cell Cycle, 10(7), pp.1144~1151 (2011)
- Ron E, "Multiple primary breast and thyroid cancer", Br J Cancer, 49(1), pp.87~92 (1984)
- Stewart AJ, "Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells", J Biol Chem, 265(34), pp.21172~21178 (1990)
- Turken O, "Breast cancer in association with thyroid disorders", Breast Cancer Res, 5(5), pp.110~R113 (2003)
- Giani C, "Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy", J Clin Endocrinol Metab, 81(3), pp.990~994 (1996)
- Metindir J, "Ovarian cyst formation in patients using tamoxifen for breast cancer", Jpn J Clin Oncol, 35(10), pp.607~611 (2005)
- Clemons M, "Estrogen and the risk of breast cancer", N Engl J Med, 344(4), pp.276~285 (2001)
- Olive DL, "Endometriosis", N Engl J Med, 328, pp.1759~1769 (1993)
- Giudice LC, "Endometriosis", Lancet, 364(9447), pp.1789~1799 (2004)
- Brinton LA, "Cancer risk after a hospital discharge diagnosis of endometriosis", Am J Obstet Gynecol, 176(3), pp.572~579 (1997)